Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease

Gynecologic and Obstetric Investigation

Volumn 46, Issue 1, 1998, Pages 5-8

  Matsui, Hideo ^a   Iitsuka, Yoshinori ^a   Seki, Katsuyoshi ^a   Sekiya, Souei ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Gestational trophoblastic disease; Primary remission rate

Indexed keywords

CHORIONIC GONADOTROPIN; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE;

ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; REMISSION; TROPHOBLASTIC DISEASE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN; DACTINOMYCIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HEMATOLOGIC DISEASES; HEPATITIS, TOXIC; HUMANS; METHOTREXATE; PREGNANCY; REMISSION INDUCTION; RISK FACTORS; TROPHOBLASTIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0031879053     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000009987     Document Type: Article

References (11)

1. Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;174:1917-1924.
2. Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB: 5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994;54:76-79.
3. Berkowitz RS, Goldstein DP, Bernstein MR: Ten years' experience with methotrexate and folic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986;23: 111-118.
4. Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS: The role of low-dose methotrexate and folic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989; 96:795-802.
5. Newlands ES, Bagshawe KD: Anti-tumor activity of the epipodophyllin derivative VP16-213 (etoposide:NSC-141540) in gestational choriocarcinoma. Eur J Cancer 1979;16:401-405.
6. Matsui H, Iitsuka Y, Seki K, Sekiya S: Etoposide (VP-16) as first-line single agent chemotherapeutic drug in low-risk gestational trophoblastic disease. Int J Gynecol Cancer 1997;7: 400-404.
7. Hammond CB, Borchert LG, Tyrey L, Creasman WT, Parker RT: Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 1973;115:451-457.
8. Wong LC, Choo YC, Ma HK: Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 1985;152:59-62.
9. Wong LC, Choo YC, Ma HK: Primary oral etoposide therapy in gestational trophoblastic disease: An update. Cancer 1986;58:14-17.
10. Matsui H, Seki K, Sekiya S, Takamizawa H: Reproductive status of patients with gestational trophoblastic disease treated with etoposide. J Reprod Med 1997;42:104-110.
11. Rustin GJS, Newlands ES, Lutz J-M, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S, Short D: Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 1996;14:2769-2773.